177 related articles for article (PubMed ID: 7697600)
1. A phase II trial of extracorporeal plasma immunoadsorption of patient plasma with PROSORBA columns for treating metastatic breast cancer.
Fennelly DW; Norton L; Sznol M; Hakes TB
Cancer; 1995 Apr; 75(8):2099-102. PubMed ID: 7697600
[TBL] [Abstract][Full Text] [Related]
2. Modulation of immunity in patients with autoimmune disease and cancer treated by extracorporeal immunoadsorption with PROSORBA columns.
Snyder HW; Balint JP; Jones FR
Semin Hematol; 1989 Apr; 26(2 Suppl 1):31-41. PubMed ID: 2543085
[TBL] [Abstract][Full Text] [Related]
3. Treatment of patients with HIV thrombocytopenia and hemolytic uremic syndrome with protein A (Prosorba column) immunoadsorption.
Mittelman A; Bertram J; Henry DH; Snyder HW; Messerschmidt GL; Ciavarella D; Ainsworth S; Kiprov D; Arlin Z
Semin Hematol; 1989 Apr; 26(2 Suppl 1):15-8. PubMed ID: 2658095
[TBL] [Abstract][Full Text] [Related]
4. Specificity of antibody responses affected by extracorporeal immunoadsorption of plasma over columns of protein A silica.
Snyder HW; Seawell BW; Cochran SK; Balint JP; Jones FR
J Clin Apher; 1992; 7(3):110-8. PubMed ID: 1337544
[TBL] [Abstract][Full Text] [Related]
5. Treatment of cancer chemotherapy-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome by protein A immunoadsorption of plasma.
Snyder HW; Mittelman A; Oral A; Messerschmidt GL; Henry DH; Korec S; Bertram JH; Guthrie TH; Ciavarella D; Wuest D
Cancer; 1993 Mar; 71(5):1882-92. PubMed ID: 8448753
[TBL] [Abstract][Full Text] [Related]
6. Minimal toxicity during protein A immunoadsorption treatment of malignant disease: an outpatient therapy.
Snyder HW; Henry DH; Messerschmidt GL; Mittelman A; Bertram J; Ambinder E; Kiprov D; Balint JP; MacKintosh FR; Hamburger M
J Clin Apher; 1991; 6(1):1-10. PubMed ID: 2045375
[TBL] [Abstract][Full Text] [Related]
7. Protein A immunoadsorption in the treatment of malignant disease.
Messerschmidt GL; Henry DH; Snyder HW; Bertram J; Mittelman A; Ainsworth S; Fiore J; Viola MV; Louie J; Ambinder E
J Clin Oncol; 1988 Feb; 6(2):203-12. PubMed ID: 3276821
[TBL] [Abstract][Full Text] [Related]
8. The effect of immunoadsorption therapy by a protein A column on patients with thrombocytopenia.
Muroi K; Sasaki R; Miura Y
Semin Hematol; 1989 Apr; 26(2 Suppl 1):10-4. PubMed ID: 2658094
[TBL] [Abstract][Full Text] [Related]
9. Experience with protein A-immunoadsorption in treatment-resistant adult immune thrombocytopenic purpura.
Snyder HW; Cochran SK; Balint JP; Bertram JH; Mittelman A; Guthrie TH; Jones FR
Blood; 1992 May; 79(9):2237-45. PubMed ID: 1571540
[TBL] [Abstract][Full Text] [Related]
10. Vasculitis secondary to staphylococcal Protein A immunoadsorption (Prosorba column) treatment in rheumatoid arthritis.
Deodhar A; Allen E; Daoud K; Wahba I
Semin Arthritis Rheum; 2002 Aug; 32(1):3-9. PubMed ID: 12219317
[TBL] [Abstract][Full Text] [Related]
11. Response of patients with IgM and IgA-associated peripheral polyneuropathies to "off-line" immunoadsorption treatment using the Prosorba protein A column.
Niemierko E; Weinstein R
J Clin Apher; 1999; 14(4):159-62. PubMed ID: 10611624
[TBL] [Abstract][Full Text] [Related]
12. Reduction in platelet-binding immunoglobulins and improvement in platelet counts in patients with HIV-associated idiopathic thrombocytopenia purpura (ITP) following extracorporeal immunoadsorption of plasma over staphylococcal protein A-silica.
Snyder HW; Bertram JH; Channel M; Ernst NR; Balint JP; Jones FR
Artif Organs; 1989 Feb; 13(1):71-7. PubMed ID: 2540735
[TBL] [Abstract][Full Text] [Related]
13. Acute glomerulonephritis occurring during immunoadsorption with staphylococcal protein A column (Prosorba).
Iglesias J; D'Agati VD; Levine JS
Nephrol Dial Transplant; 2004 Dec; 19(12):3155-9. PubMed ID: 15575004
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin binding properties of the Prosorba immunadsorption column in treatment of rheumatoid arthritis.
Sasso EH; Merrill C; Furst TE
Ther Apher; 2001 Apr; 5(2):84-91. PubMed ID: 11354304
[TBL] [Abstract][Full Text] [Related]
15. Clinical trials with staphylococcal protein A.
Bensinger WI; Buckner CD; Clift RA; Thomas ED
J Biol Response Mod; 1984; 3(3):347-51. PubMed ID: 6379119
[TBL] [Abstract][Full Text] [Related]
16. Modulation of idiotypic and antiidiotypic immunoglobulin G responses in an immune thrombocytopenic purpura patient as a consequence of extracorporeal protein A immunoadsorption.
Balint JP; Cochran SK; Jones FR
Artif Organs; 1995 Jun; 19(6):496-9. PubMed ID: 8526787
[TBL] [Abstract][Full Text] [Related]
17. Evidence for proteolytic cleavage of covalently bound protein A from a silica based extracorporeal immunoadsorbent and lack of relationship to treatment effects.
Balint JP; Jones FR
Transfus Sci; 1995 Mar; 16(1):85-94. PubMed ID: 10155709
[TBL] [Abstract][Full Text] [Related]
18. Immune modulation associated with extracorporeal immunoadsorption treatments utilizing protein A/silica columns.
Balint JP
Artif Organs; 1996 Aug; 20(8):906-13. PubMed ID: 8853805
[TBL] [Abstract][Full Text] [Related]
19. Toxicity following protein A treatment of metastatic breast adenocarcinoma.
Ainsworth SK; Pilia PA; Pepkowitz SH; O'Brien P
Cancer; 1988 Apr; 61(8):1495-500. PubMed ID: 3349417
[TBL] [Abstract][Full Text] [Related]
20. A randomized double-blind sham-controlled trial of the Prosorba column for treatment of refractory rheumatoid arthritis.
Gendreau RM;
Ther Apher; 2001 Apr; 5(2):79-83. PubMed ID: 11354303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
